scispace - formally typeset
N

Noam Nissan

Researcher at Sheba Medical Center

Publications -  44
Citations -  743

Noam Nissan is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Medicine & Breast cancer. The author has an hindex of 11, co-authored 31 publications receiving 437 citations. Previous affiliations of Noam Nissan include Tel Aviv University & Weizmann Institute of Science.

Papers
More filters
Journal ArticleDOI

Diffusion-weighted breast MRI: Clinical applications and emerging techniques

TL;DR: Technical innovations are helping to overcome many of the image quality issues that have limited widespread use of DWI for breast imaging and advanced modeling approaches to further characterize tissue perfusion, complexity, and glandular organization may expand knowledge and yield improved diagnostic tools.
Journal ArticleDOI

Diffusion-Tensor MR Imaging of the Breast: Hormonal Regulation

TL;DR: DTI parameters are not sensitive to menstrual cycle changes, while menopause, long-term HRT, and presence of milk in lactating women affected the DTI parameters.
Journal ArticleDOI

Can diffusion tensor anisotropy indices assist in breast cancer detection

TL;DR: To evaluate whether the various anisotropy indices derived from breast diffusion tensor imaging (DTI) can characterize the healthy breast structure and differentiate cancer from normal breast tissue, a large number of patients were diagnosed with breast cancer.
Journal ArticleDOI

COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.

TL;DR: In this article, an increase in axillary-lymphadenopathy attributed to vaccination was found in 163 women undergoing breast-imaging, including BRCA-carriers.
Journal ArticleDOI

Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results

TL;DR: Diffusion tensor imaging (DTI) yields several parameters that have not been tested in response evaluation to neoadjuvant chemotherapy (NAC) and need to be tested in further studies.